Radka Lohynská

1.3k total citations
37 papers, 560 citations indexed

About

Radka Lohynská is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Radka Lohynská has authored 37 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 12 papers in Surgery. Recurrent topics in Radka Lohynská's work include Brain Metastases and Treatment (13 papers), Lung Cancer Research Studies (9 papers) and Glioma Diagnosis and Treatment (8 papers). Radka Lohynská is often cited by papers focused on Brain Metastases and Treatment (13 papers), Lung Cancer Research Studies (9 papers) and Glioma Diagnosis and Treatment (8 papers). Radka Lohynská collaborates with scholars based in Czechia, United States and Germany. Radka Lohynská's co-authors include Steven E. Schild, Dirk Rades, Theo Veninga, Lukas J.A. Stalpers, Juergen Dunst, Liesa Dziggel, Martin Oliverius, Jana Votrubová, Eva Sedláčková and V. Stahalova and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Radka Lohynská

28 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radka Lohynská Czechia 14 401 339 180 127 92 37 560
N. Coliarakis Greece 5 427 1.1× 270 0.8× 181 1.0× 73 0.6× 172 1.9× 8 549
H. Selim United States 8 376 0.9× 286 0.8× 108 0.6× 64 0.5× 65 0.7× 12 496
Cem Parlak Türkiye 11 156 0.4× 148 0.4× 49 0.3× 72 0.6× 150 1.6× 30 398
Yanqun Dong United States 10 145 0.4× 118 0.3× 43 0.2× 60 0.5× 46 0.5× 13 307
Shravan Kandula United States 11 433 1.1× 143 0.4× 294 1.6× 48 0.4× 55 0.6× 18 521
T. Gadalla Canada 6 161 0.4× 137 0.4× 56 0.3× 124 1.0× 50 0.5× 7 393
Anna Santacaterina Italy 11 148 0.4× 181 0.5× 32 0.2× 217 1.7× 58 0.6× 39 443
Charlotte Kristiansen Denmark 10 144 0.4× 105 0.3× 64 0.4× 62 0.5× 92 1.0× 36 316
M. Paraskevaidis Greece 4 326 0.8× 243 0.7× 185 1.0× 55 0.4× 65 0.7× 12 392
Irving J. Weigensberg United States 8 248 0.6× 230 0.7× 98 0.5× 139 1.1× 65 0.7× 12 425

Countries citing papers authored by Radka Lohynská

Since Specialization
Citations

This map shows the geographic impact of Radka Lohynská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radka Lohynská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radka Lohynská more than expected).

Fields of papers citing papers by Radka Lohynská

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radka Lohynská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radka Lohynská. The network helps show where Radka Lohynská may publish in the future.

Co-authorship network of co-authors of Radka Lohynská

This figure shows the co-authorship network connecting the top 25 collaborators of Radka Lohynská. A scholar is included among the top collaborators of Radka Lohynská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radka Lohynská. Radka Lohynská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiala, Ondřej, Petr Hošek, Bohuslav Melichar, et al.. (2025). Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab. Clinical & Experimental Metastasis. 42(5). 43–43.
2.
Lohynská, Radka, et al.. (2024). Adverse effects of radiotherapy and radiobiological modelling. 18(2). 137–141.
3.
Vošmik, Milan, Josef Dvořák, Beatrice Mohelníková-Duchoňová, et al.. (2024). Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial. Oncology and Therapy. 12(4). 817–831. 1 indexed citations
4.
Boublíková, Ludmila, et al.. (2023). Total neoadjuvant therapy in rectal cancer: the evidence and expectations. Critical Reviews in Oncology/Hematology. 192. 104196–104196. 19 indexed citations
5.
Lohynská, Radka, et al.. (2023). Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer. Strahlentherapie und Onkologie. 199(10). 881–890. 3 indexed citations
6.
Lohynská, Radka, et al.. (2022). Capecitabine in the treatment of anal squamous cell carcinoma. Klinicka onkologie. 35(1). 38–43.
7.
Lohynská, Radka, et al.. (2021). Tumour volume and radiotherapy prolongation in locally advanced head and neck cancer patients treated with radical IMRT. Biomedical Papers. 166(4). 405–411. 2 indexed citations
8.
Lohynská, Radka, et al.. (2020). Radiotherapy dose limit for uterus fertility sparing in curative chemoradiotherapy for rectal cancer. Biomedical Papers. 165(1). 99–101. 11 indexed citations
9.
Lohynská, Radka, et al.. (2020). Haematotoxicity in IMRT/VMAT curatively treated anal cancer.. PubMed. 33(4). 288–294. 3 indexed citations
10.
11.
Rades, Dirk, Liesa Dziggel, Viorica Nagy, et al.. (2013). A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone. Radiotherapy and Oncology. 108(1). 123–127. 36 indexed citations
12.
Rades, Dirk, et al.. (2011). Dose‐escalation of whole‐brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer. 118(15). 3852–3859. 56 indexed citations
13.
Rades, Dirk, et al.. (2011). Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients. International Journal of Radiation Oncology*Biology*Physics. 81(4). e469–e473. 17 indexed citations
14.
Rades, Dirk, Liesa Dziggel, Theo Veninga, et al.. (2010). Scoring Systems to Estimate Intracerebral Control and Survival Rates of Patients Irradiated for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 80(4). 1122–1127. 48 indexed citations
15.
Lohynská, Radka, et al.. (2009). Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC). Clinical Neurology and Neurosurgery. 112(3). 183–187. 5 indexed citations
16.
Rades, Dirk, et al.. (2008). Surgical Resection Followed by Whole Brain Radiotherapy Versus Whole Brain Radiotherapy Alone for Single Brain Metastasis. International Journal of Radiation Oncology*Biology*Physics. 70(5). 1319–1324. 35 indexed citations
17.
Rades, Dirk, Radka Lohynská, Theo Veninga, et al.. (2007). Whole-Brain Radiotherapy with 20 Gy in 5 Fractions for Brain Metastases in Patients with Cancer of Unknown Primary (CUP). Strahlentherapie und Onkologie. 183(11). 631–636. 24 indexed citations
18.
Rades, Dirk, Radka Lohynská, Theo Veninga, Lukas J.A. Stalpers, & Steven E. Schild. (2007). Evaluation of 2 whole‐brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer. 110(11). 2587–2592. 29 indexed citations
19.
Rades, Dirk, Steven E. Schild, Radka Lohynská, et al.. (2007). Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer. 110(5). 1077–1082. 26 indexed citations
20.
Votrubová, Jana, Otakar Bělohlávek, Martin Oliverius, et al.. (2006). The role of FDG-PET/CT in the detection of recurrent colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 33(7). 779–784. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Coliarakis Breakdown of academic impact, for papers by H. Selim Breakdown of academic impact, for papers by Cem Parlak Breakdown of academic impact, for papers by Yanqun Dong Breakdown of academic impact, for papers by Shravan Kandula Breakdown of academic impact, for papers by T. Gadalla Breakdown of academic impact, for papers by Anna Santacaterina Breakdown of academic impact, for papers by Charlotte Kristiansen Breakdown of academic impact, for papers by M. Paraskevaidis Breakdown of academic impact, for papers by Irving J. Weigensberg
Rankless by CCL
2026